Today, Mizuho Trust & Banking Co. Ltd. Reduced the position of Envision Healthcare Holdings Inc. (EVHC)

Today, Mizuho Trust & Banking Co. Ltd. Reduced the position of Envision Healthcare Holdings Inc. (EVHC)
Mizuho Trust & Banking Co. Ltd. lowered its position in shares of Envision Healthcare Holdings Inc. (NYSE:EVHC) by 0.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 300,192 shares of the company’s stock after selling 1,362 shares during the period. Mizuho Trust & Banking Co. Ltd. owned approximately 0.16% of Envision Healthcare Holdings worth $6,685,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Daiwa Securities Group Inc. increased its position in shares of Envision Healthcare Holdings by 11.9% in the second quarter. Daiwa Securities Group Inc. now owns 4,700 shares of the company’s stock worth $119,000 after buying an additional 500 shares during the last quarter. Seven Bridges Advisors LLC bought a new position in shares of Envision Healthcare Holdings during the third quarter worth about $119,000. LS Investment Advisors LLC increased its position in shares of Envision Healthcare Holdings by 23.8% in the second quarter. LS Investment Advisors LLC now owns 5,066 shares of the company’s stock worth $129,000 after buying an additional 974 shares during the last quarter. First New York Securities LLC NY bought a new position in shares of Envision Healthcare Holdings during the third quarter worth about $134,000. Finally, Nordea Investment Management AB increased its position in shares of Envision Healthcare Holdings by 9.8% in the second quarter. Nordea Investment Management AB now owns 5,457 shares of the company’s stock worth $138,000 after buying an additional 488 shares during the last quarter.

Envision Healthcare Holdings Inc. (NYSE:EVHC) traded up 1.15% during trading on Thursday, reaching $21.92. 1,227,070 shares of the company’s stock traded hands. The company has a 50 day moving average of $21.41 and a 200 day moving average of $23.13. The firm has a market cap of $4.11 billion, a price-to-earnings ratio of 34.25 and a beta of 0.49. Envision Healthcare Holdings Inc. has a one year low of $18.31 and a one year high of $28.47.

Envision Healthcare Holdings (NYSE:EVHC) last released its earnings results on Tuesday, November 1st. The company reported $0.36 earnings per share for the quarter, hitting the consensus estimate of $0.36. Envision Healthcare Holdings had a return on equity of 11.96% and a net margin of 1.93%. The business earned $1.64 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period last year, the company earned $0.30 earnings per share. The business’s revenue for the quarter was up 19.8% compared to the same quarter last year. Equities research analysts predict that Envision Healthcare Holdings Inc. will post $1.39 EPS for the current year.

A number of research analysts have issued reports on the stock. Jefferies Group reduced their price objective on shares of Envision Healthcare Holdings from $35.00 to $32.00 and set a “buy” rating on the stock in a research report on Thursday, August 4th. Zacks Investment Research downgraded shares of Envision Healthcare Holdings from a “hold” rating to a “sell” rating in a research report on Friday, August 5th. Canaccord Genuity reissued a “buy” rating and set a $32.00 price objective on shares of Envision Healthcare Holdings in a research report on Friday, August 5th. Cantor Fitzgerald reissued a “buy” rating and set a $31.00 price objective on shares of Envision Healthcare Holdings in a research report on Thursday, September 8th. Finally, Citigroup Inc. raised shares of Envision Healthcare Holdings from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $27.00 to $26.00 in a research report on Monday, September 26th. Six analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $29.82.

Envision Healthcare Holdings Company Profile

Related posts

Leave a Comment